Medical Industry Technology In United Kingdom

GW is the global leader in developing cannabinoid-based medicines. GW has been researching cannabinoids since 1998 and has established a world leading position in the development of plant-derived cannabinoid therapeutics. GW has established a world ...

Our patent protected platform combines microfluidic processes, electroanalytical and immunochemical sensors, with the output read and interpreted by a handheld reader. This miniaturisation offers quantitative, near patient results. Software in the ...

Orthonika is a spin-out company from Imperial College London. It is the result of a collaboration between Imperial College and Sierra MedTech and aims to develop and commercialise a novel anatomical Total Meniscus Replacement. We are combining world ...

Attomarker is a British company focused on nanophotonic biochemical testing. It was founded in 2008, and spun out from Professor Andrew Shaw’s research group at the University of Exeter. It has won numerous prestigious awards for innovation and been ...

Extra-corporeal treatments like dialysis, cardiopulmonary bypass, and ECMO involve the circulation of the patient's blood supply through a machine. The patient's immune system treats the machine as a large, unwanted foreign body; the resulting ...

Based in Cambridge, one of Europe's largest bioscience hubs, Biorbyt has a simple yet challenging mission: to provide the best service to the global scientific community. We achieve this by collaborating with the world’s finest researchers and ...

Our cutting-edge technology is transforming the market with the incredible potential of microalgae, offering sustainable and eco-friendly solutions for a brighter future. At API, we have mastered the art of separating algae and harnessing its full ...

Founded in 2015, the original idea behind Airfinity was to systematically capture and structure the new science disseminated at conferences, a highly fragmented dataset. However, through working with medical associations and pharma companies, ...

Embody is a spin-out company from Imperial College London. We are a team of specialists from a variety of engineering, medical, and design backgrounds. Embody provides pre-operative planning, patient specific instruments and complex surgical ...

Vaccitech is a clinical stage T cell immunotherapy and vaccine company developing products to treat and prevent infectious disease and cancer. The company’s proprietary heterologous prime-boost platform comprises Chimpanzee Adenovirus Oxford ...

Lightcast is developing a cell manipulation platform that utilises tiny spots of light to control thousands of cells and reagents at once, enabling game-changing workflows for the pharmaceutical industry. With applications ranging from ...

SI-BONE was founded in April 2008, as a spin out when Wright Medical bought INBONE Technologies. INBONE, with the ENDO-FUSETM Intra-Osseous Fusion System, was founded by Dr. Mark Reiley, the inventor of kyphoplasty and the vertebral fracture ...

Quanta Dialysis Technologies is making dialysis more accessible to every patient in every setting with its SC+ hemodialysis system. SC+ is an end-to-end solution with performance comparable to a large traditional machine, and all the flexibility you ...

Founded in 2012 at University of Manchester, Gelmetix is a UK medtech company focused on treating chronic lower back pain caused by the degeneration of the intervertebral discs. Gelmetix’s polymer gel technology also has the potential to be adapted ...

Sherlock Biosciences is pioneering advancements in molecular diagnostics by leveraging CRISPR and synthetic biology technologies. The company's proprietary platforms, such as the CRISPR-based SHERLOCK™ and synthetic biology-based INSPECTR™, are ...

Less than 3% of all conversations on social media about Climate Change contain any mention of energy efficiency. Yet it is definitively the fastest, cleanest and most cost-effective solution - expected to make up 43% of the ‘sustainable development ...

Our experienced board and management team guides Linear Diagnostics to maximise the opportunites that are emerging within the healthcare and diagnostic markets. The company’s board and management team comprises experienced medical diagnostics ...

Edinburgh Molecular Imaging is a clinical phase biotechnology company focused on enabling image guided interventional medicine. The company´s molecular targetting technology has the potential to tackle disease in real-time to allow interventional ...

Our goal is to transform animal health through data intelligence. We will create the first integrated biomarker, health microchip and activity monitor for pets and livestock, for real time remote health monitoring, early detection of disease, ...

Getting ahead of cancer is crucial no matter where people are in their cancer journey. From earlier cancer detection to treatment guidance and monitoring, we are helping people get the answers they need to make more informed decisions across the ...